Enhancing FibroScan® liver disease assessment with biological markers
A single biomarker cannot answer to all questions.
With Scores FibroScan® based, you can combine FibroScan® results with other parameters to get the best performance and a better identification of your patients.
Scores FibroScan® based are available on myFibroScan application.
Suspected MASLD patients
MASH + NAS≥4 + F≥2
Screening for clinical trial and identifying at-risk MASH patients (Formerly NASH)
FibroScan® results (LSM by VCTE™ & CAP™) + laboratory parameter (AST)
Suspected MASLD patients
F≥3
Identifying MASLD patients with advanced fibrosis and predicting risk of complications
LSM by VCTE™ + Clinical parameters (AST, ALT, Platelets, Presence of Diabetes, Age and Gender)
Suspected MASLD patients
F4
Identifying MASLD patients with cirrhosis that need to be screen for HCC
LSM by VCTE™ + Clinical parameters (AST, ALT, Platelets, Presence of Diabetes and Gender)
The non-invasive gold standard solution for comprehensive management of liver health
Cloud-based solution to assist clinicians in providing comprehensive liver care.
Your everyday FibroScan® companion – free application
Fast is an algorithm intended to aid in the diagnosis of active fibrotic Non-Alcoholic Steatohepatitis (NASH) in patients with suspected Non-Alcoholic Fatty Liver Disease (NAFLD). Fast is used, during liver assessment, in patient with suspected NAFLD. The following precautions must be observed when using Fast: LSM (also known as E) and CAP™ measurements must come from the same FibroScan® examination; There must be no more than 6 months between the FibroScan® examination and the blood sample necessary for AST assessment. Fast must not be used in the following situations : pregnancy, patients under 18 years old, chronic or acute liver diseases other than NAFLD, liver transplant patients, cardiac failure and/or significant vascular disease, confirmed diagnosis of active malignancy or other terminal disease, use of treatment inducing liver injury. Agile 3+ calculator is a tool for clinicians, computed from LSM (obtained from FibroScan® device), AST, ALT, platelets, diabetes status, age and gender, to aid in the identification of patients with suspicion of NAFLD as having advanced fibrosis. It was developed based on a pool of retrospective cohorts and published in peer-reviewed literature. Agile 4 calculator is a tool for clinicians, computed from LSM (obtained from FibroScan® device), AST, ALT, platelets, diabetes status and gender, to aid in the identification of patients with suspicion of NAFLD as having cirrhosis. It was developed based on a pool of retrospective cohorts and published in peer-reviewed literature. Fast, Agile 3+ and Agile 4 are presented as educational services intended for licensed healthcare professionals. While these scores are about specific medical and health issues,they are not a substitute for or a replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.
FibroScan®
